Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Kahn Brothers Group, latest 13F

Bristol-Myers Squibb

In Kahn Brothers Group's portfolio · Kahn Brothers Group

Ticker BMY

Still in the portfolio as of Q3 2026. Every quarter it shows up in a Kahn Brothers Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2026 Reduce 11% 155,297 1.6% $62.40 $9.7M
Q2 2026 Add 2% 174,152 1.6% $57.62 $10.0M
Q1 2026 Reduce 16% 170,381 1.8% $60.65 $10.3M
Q4 2025 Reduce 26% 202,196 1.9% $53.94 $10.9M
Q3 2025 Reduce 51% 272,334 2.3% $45.10 $12.3M
Q2 2025 Reduce 8% 550,683 5.1% $46.29 $25.5M
Q1 2025 Reduce 13% 597,428 7.4% $60.99 $36.4M
Q4 2024 Reduce 16% 690,252 8.5% $56.56 $39.0M
Q3 2024 No change 826,108 7.4% $51.74 $42.7M
Q2 2024 Reduce 1% 827,258 5.8% $41.53 $34.4M
Q1 2024 No change 831,991 6.7% $54.23 $45.1M
Q4 2023 Reduce 2% 833,916 6.7% $51.31 $42.8M
Q3 2023 Reduce 2% 851,699 7.7% $58.06 $49.5M
Q2 2023 Reduce 3% 871,244 9.0% $70.38 $61.3M
Q1 2023 Reduce 1% 900,556 9.0% $69.31 $62.4M
Q4 2022 Reduce 1% 914,001 8.7% $71.95 $65.8M
Q3 2022 Reduce 1% 924,093 10.2% $71,090.30 $65.69B
Q2 2022 No change 928,865 9.6% $77,000.34 $71.52B
Q1 2022 No change 925,728 8.6% $73,030.19 $67.61B
Q4 2021 Add 5% 921,603 7.9% $62,350.00 $57.46B
Q3 2021 Reduce 2% 873,730 7.3% $59,170.00 $51.70B
Q2 2021 Add 6% 893,045 8.4% $65,323.55 $58.34B
Q1 2021 Reduce 2% 846,336 8.3% $63,130.00 $53.43B
Q4 2020 Reduce 8% 864,237 9.4% $62,030.00 $53.61B
Q3 2020 Reduce 8% 935,977 10.7% $60,290.00 $56.43B
Q2 2020 Reduce 1% 1,015,804 10.1% $58,800.00 $59.73B
Q1 2020 Reduce 3% 1,026,209 10.5% $55,740.00 $57.20B
Q4 2019 Reduce 2% 1,053,732 8.2% $64,190.00 $67.64B
Q3 2019 Add 5% 1,072,760 6.8% $50,710.00 $54.40B
Q2 2019 Add 102% 1,018,280 5.8% $45,350.00 $46.18B
Q1 2019 Add 2428% 504,350 3.8% $47,710.00 $24.06B
Q4 2018 No change 19,950 0.2% $51,980.00 $1.04B
Q3 2018 No change 19,950 0.2% $62,080.00 $1.24B
Q2 2018 Add 1% 19,950 0.2% $55,340.00 $1.10B
Q1 2018 Add 4% 19,750 0.2% $63,250.03 $1.25B
Q4 2017 No change 19,050 0.2% $61,280.00 $1.17B
Q3 2017 Reduce 3% 19,050 0.2% $63,740.00 $1.21B
Q2 2017 Reduce 31% 19,583 0.2% $55,720.01 $1.09B
Q1 2017 No change 28,583 0.3% $54,380.02 $1.55B
Q4 2016 No change 28,583 0.3% $58,440.02 $1.67B
Q3 2016 No change 28,583 0.3% $53,919.99 $1.54B
Q2 2016 No change 28,583 0.4% $73,515.03 $2.10B
Q1 2016 Add 2% 28,583 0.3% $63,880.00 $1.83B
Q4 2015 Reduce 3% 28,050 0.3% $68,790.02 $1.93B
Q3 2015 No change 28,800 0.3% $59,200.00 $1.70B
Q2 2015 Add 1% 28,800 0.3% $66,540.00 $1.92B
Q1 2015 No change 28,400 0.3% $64,500.00 $1.83B
Q4 2014 Add 3% 28,400 0.3% $59,030.00 $1.68B
Q3 2014 No change 27,650 0.2% $51,180.00 $1.42B
Q2 2014 Reduce 7% 27,650 0.2% $48,510.02 $1.34B
Q1 2014 Add 7% 29,650 0.2% $51,950.02 $1.54B
Q4 2013 Reduce 2% 27,650 0.3% $53,150.02 $1.47B
Q3 2013 Reduce 49% 28,300 0.2% $46,280.00 $1.31B
Q2 2013 First 13F 55,433 0.4% $44,690.35 $2.48B

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.